ACAD vs. TPR
Compare and contrast key facts about ACADIA Pharmaceuticals Inc. (ACAD) and Tapestry, Inc. (TPR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ACAD or TPR.
Key characteristics
| ACAD | TPR | |
|---|---|---|
| YTD Return | -52.92% | 36.44% |
| 1Y Return | -33.69% | 80.93% |
| 3Y Return (Ann) | -6.38% | 11.52% |
| 5Y Return (Ann) | -19.11% | 16.70% |
| 10Y Return (Ann) | -6.13% | 6.93% |
| Sharpe Ratio | -0.58 | 2.54 |
| Sortino Ratio | -0.64 | 3.57 |
| Omega Ratio | 0.91 | 1.40 |
| Calmar Ratio | -0.43 | 1.59 |
| Martin Ratio | -0.81 | 8.25 |
| Ulcer Index | 39.75% | 10.18% |
| Daily Std Dev | 55.93% | 33.11% |
| Max Drawdown | -96.29% | -82.39% |
| Current Drawdown | -74.14% | -9.58% |
Fundamentals
| ACAD | TPR | |
|---|---|---|
| Market Cap | $2.45B | $11.75B |
| EPS | $0.19 | $3.40 |
| PE Ratio | 77.58 | 14.42 |
| PEG Ratio | -0.42 | 1.62 |
| Total Revenue (TTM) | $678.84M | $5.16B |
| Gross Profit (TTM) | $619.76M | $3.65B |
| EBITDA (TTM) | $90.33M | $1.08B |
Correlation
The correlation between ACAD and TPR is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ACAD vs. TPR - Performance Comparison
In the year-to-date period, ACAD achieves a -52.92% return, which is significantly lower than TPR's 36.44% return. Over the past 10 years, ACAD has underperformed TPR with an annualized return of -6.13%, while TPR has yielded a comparatively higher 6.93% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ACAD vs. TPR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ACADIA Pharmaceuticals Inc. (ACAD) and Tapestry, Inc. (TPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ACAD vs. TPR - Dividend Comparison
ACAD has not paid dividends to shareholders, while TPR's dividend yield for the trailing twelve months is around 2.86%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACAD ACADIA Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TPR Tapestry, Inc. | 2.86% | 3.53% | 2.89% | 1.23% | 1.09% | 5.01% | 4.00% | 3.05% | 3.85% | 4.12% | 3.59% | 2.34% |
Drawdowns
ACAD vs. TPR - Drawdown Comparison
The maximum ACAD drawdown since its inception was -96.29%, which is greater than TPR's maximum drawdown of -82.39%. Use the drawdown chart below to compare losses from any high point for ACAD and TPR. For additional features, visit the drawdowns tool.
Volatility
ACAD vs. TPR - Volatility Comparison
The current volatility for ACADIA Pharmaceuticals Inc. (ACAD) is 8.11%, while Tapestry, Inc. (TPR) has a volatility of 14.31%. This indicates that ACAD experiences smaller price fluctuations and is considered to be less risky than TPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ACAD vs. TPR - Financials Comparison
This section allows you to compare key financial metrics between ACADIA Pharmaceuticals Inc. and Tapestry, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities